Ducommun, S.* ; Deak, M.* ; Zeigerer, A. ; Göransson, O.* ; Seitz, S. ; Collodet, C.* ; Madsen, A.B.* ; Jensen, T.E.* ; Viollet, B.* ; Foretz, M.* ; Gut, P.* ; Sumpton, D.* ; Sakamoto, K.*
Chemical genetic screen identifies Gapex-5/GAPVDI and STBD1 as novel AMPK substrates.
Cell. Signal. 57, 45-57 (2019)
AMP-activated protein kinase (AMPK) is a key regulator of cellular energy homeostasis, acting as a sensor of energy and nutrient status. As such, AMPK is considered a promising drug target for treatment of medical conditions particularly associated with metabolic dysfunctions. To better understand the downstream effectors and physiological consequences of AMPK activation, we have employed a chemical genetic screen in mouse primary hepatocytes in an attempt to identify novel AMPK targets. Treatment of hepatocytes with a potent and specific AMPK activator 991 resulted in identification of 65 proteins phosphorylated upon AMPK activation, which are involved in a variety of cellular processes such as lipid/glycogen metabolism, vesicle trafficking, and cytoskeleton organisation. Further characterisation and validation using mass spectrometry followed by immunoblotting analysis with phosphorylation site-specific antibodies identified AMPK-dependent phosphorylation of Gapex-5 (also known as GTPase-activating protein and VPS9 domain-containing protein 1 (GAPVD1)) on Ser902 in hepatocytes and starch-binding domain 1 (STBD1) on Ser175 in multiple cells/tissues. As new promising roles of AMPK as a key metabolic regulator continue to emerge, the substrates we identified could provide new mechanistic and therapeutic insights into AMPK-activating drugs in the liver.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Gtpase Activating Protein And Vps9 Domains 1 ; Shokat ; Starch-binding Domain 1; Activated Protein-kinase; Acetyl-coa Carboxylase; Skeletal-muscle; Fatty-acid; Glucose-uptake; Mitochondrial Fission; Insulin-resistance; Hepatic Steatosis; Glycogen-synthase; Molecular-cloning
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
0898-6568
e-ISSN
0898-6568
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 57,
Issue: ,
Pages: 45-57
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-501900-254
Grants
Copyright
Erfassungsdatum
2019-03-11